Mental Health & Psychiatry — UKMLA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — SNRI (e.g. duloxetine)
Choose B — SNRI. Duloxetine is a serotonin–norepinephrine reuptake inhibitor that treats major depressive disorder and has established analgesic indications, including diabetic peripheral neuropathic pain and chronic musculoskeletal pain. SNRIs enhance descending inhibitory pain pathways via norepinephrine and serotonin reuptake blockade, making duloxetine the best single antidepressant choice when depression coexists with neuropathic-type chronic back pain. SSRIs, MAOIs, and mirtazapine are not preferred for neuropathic pain; TCAs can reduce neuropathic pain but are limited by anticholinergic, sedating, and cardiac adverse effects and are not the class exemplified by duloxetine.
Reference: DailyMed/FDA Prescribing Information: Duloxetine delayed-release capsules, updated 2026. https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=9286ec0b-45ae-4a09-a0ad-556ec92aab63&type=display